Source
fundsforngos
Details
Pfizer has announced a Competitive Fellowship Grant Program to support clinical training in transthyretin cardiac amyloidosis, also known as ATTR cardiac amyloidosis. The programme provides grant funding of up to €50,000 to German institutions to support one fellow for up to six months. The fellowship aims to strengthen healthcare professionals’ ability to recognize, diagnose, treat, monitor, and conduct research related to ATTR cardiac amyloidosis.